The trademark application REMAKING MEDICINE was filed by EQRx International, Inc., a U.S. corporation (the "Applicant"). Application withdrawn.
The application was filed in English (French was selected as the second language).
The Refusal with reference B 018226448 was Rejected according to Article 7(1)(b) EUTMR with decision issued on August 27, 2020 by the EUIPO.
Goods And Services
The mark was filed in class 5 with Pharmaceutical and therapeutic preparations for the treatment of oncological, autoimmune, and inflammatory diseases and disorders.
The mark was filed in class 42 with Research and development of pharmaceutical and therapeutic preparations for the treatment of oncological, autoimmune, and inflammatory diseases and disorders.